254 related articles for article (PubMed ID: 6972628)
1. Indomethacin enhancement of immunocompetence in melanoma patients.
Tilden AB; Balch CM
Surgery; 1981 Jul; 90(1):77-84. PubMed ID: 6972628
[TBL] [Abstract][Full Text] [Related]
2. Immune modulatory effects of indomethacin in melanoma patients are not related to prostaglandin E2-mediated suppression.
Tilden AB; Balch CM
Surgery; 1982 Sep; 92(3):528-32. PubMed ID: 6287658
[TBL] [Abstract][Full Text] [Related]
3. In vitro inhibition of interleukin-2 production by peripheral blood lymphocytes from stage III melanoma patients by prostaglandin E2: enhancement of lymphocyte proliferation by exogenous interleukin-2 plus indomethacin.
Murray JL; Dowd J; Hersh EM
J Biol Response Mod; 1986 Feb; 5(1):12-9. PubMed ID: 3485703
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E2-mediated suppression of cellular immunity in colon cancer patients.
Balch CM; Dougherty PA; Cloud GA; Tilden AB
Surgery; 1984 Jan; 95(1):71-7. PubMed ID: 6229053
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of lymphocytes to prostaglandin E2 increases in subjects over age 70.
Goodwin JS; Messner RP
J Clin Invest; 1979 Aug; 64(2):434-9. PubMed ID: 457862
[TBL] [Abstract][Full Text] [Related]
6. In vitro effect of indomethacin on mitogen-induced lymphoproliferative response in lung cancer patients.
Stanojević-Bakić N; Vucković-Dekić L; Susnjar S; Spuzić I
Neoplasma; 1992; 39(2):129-32. PubMed ID: 1326720
[TBL] [Abstract][Full Text] [Related]
7. Immunoregulatory cell function in peripheral blood leukocytes of patients with intracranial gliomas.
Braun DP; Penn RD; Flannery AM; Harris JE
Neurosurgery; 1982 Feb; 10(2):203-9. PubMed ID: 6280097
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin suppression of mitogen-stimulated lymphocytes in vitro. Changes with mitogen dose and preincubation.
Goodwin JS; Messner RP; Peake GT
J Clin Invest; 1978 Oct; 62(4):753-60. PubMed ID: 701474
[TBL] [Abstract][Full Text] [Related]
9. Suppression of human lymphocyte responses in chronic renal failure mediated by adherent cells: analysis in serum-free media.
Kleiman KS; Zoschke DC
J Lab Clin Med; 1985 Sep; 106(3):262-8. PubMed ID: 3928781
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of suppression of the depressed lymphocyte response in lung cancer patients.
Alberola V; González-Molina A; Trenor A; San Martín B; Lluch A; Palau F; Marín J; García-Conde FJ
Allergol Immunopathol (Madr); 1985; 13(3):213-9. PubMed ID: 2931010
[TBL] [Abstract][Full Text] [Related]
11. Studies on lymphocyte hyporesponsiveness in cirrhosis: the role of increased monocyte suppressor cell activity.
Holdstock G; Chastenay BF; Krawitt EL
Gastroenterology; 1982 Feb; 82(2):206-12. PubMed ID: 6459260
[TBL] [Abstract][Full Text] [Related]
12. Depressed T cell proliferative responses in Hodgkin's disease: role of monocyte-mediated suppression via prostaglandins and hydrogen peroxide.
Fisher RI; Bostick-Bruton F
J Immunol; 1982 Oct; 129(4):1770-4. PubMed ID: 6980949
[TBL] [Abstract][Full Text] [Related]
13. Anergy in sarcoidosis: the role of interleukin-1 and prostaglandins in the depressed in vitro lymphocyte response.
Hudspith BN; Brostoff J; McNicol MW; Johnson NM
Clin Exp Immunol; 1984 Aug; 57(2):324-30. PubMed ID: 6331921
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte subpopulations and reactivity to mitogens in patients with scleroderma.
Baron M; Keystone EC; Gladman DD; Lee P; Poplonski L
Clin Exp Immunol; 1981 Oct; 46(1):70-6. PubMed ID: 6978216
[TBL] [Abstract][Full Text] [Related]
15. Monocyte PGE2 secretion in Hodgkin's disease and its relation to decreased cellular immunity.
Passwell J; Levanon M; Davidsohn J; Ramot B
Clin Exp Immunol; 1983 Jan; 51(1):61-8. PubMed ID: 6572580
[TBL] [Abstract][Full Text] [Related]
16. The response of cancer patients' lymphocytes to mitogen. The effect of indomethacin on adherent and non-adherent cells activity.
Pituch-Noworolska A
Arch Immunol Ther Exp (Warsz); 1981; 29(2):161-5. PubMed ID: 7305629
[TBL] [Abstract][Full Text] [Related]
17. Immune dysfunction in primary biliary cirrhosis (PBC): I. Increased sensitivity of PHA stimulated lymphocyte cultures to indomethacin.
Licastro F; Lenzi M; Chiricolo M; Davis LJ; Cassani F; Bianchi F; Franceschi C
J Clin Lab Immunol; 1987 May; 23(1):19-23. PubMed ID: 3612758
[TBL] [Abstract][Full Text] [Related]
18. Role of prostaglandins on lymphocyte transformation in Crohn's disease.
Echevarría S; Cajigas J; Rodríguez de Lope C; Lozano JL; Pons Romero F
Allergol Immunopathol (Madr); 1989; 17(6):317-21. PubMed ID: 2635833
[TBL] [Abstract][Full Text] [Related]
19. Indomethacin-mediated enhancement of lymphocyte response to mitogens in healthy subjects and lung cancer patients.
Han T; Takita H
Cancer; 1980 Dec; 46(11):2416-20. PubMed ID: 6969110
[TBL] [Abstract][Full Text] [Related]
20. Relationship of leukocyte numbers, immunoregulatory cell function, and phytohemagglutinin responsiveness in cancer patients.
Braun DP; Harris JE
J Natl Cancer Inst; 1981 Oct; 67(4):809-14. PubMed ID: 6974273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
